Luteinizing hormone-releasing hormone (LHRH) analogue Clinical Trials
3 recruitingDrug
Phase 23
Showing 1–3 of 3 trials
Recruiting
Phase 2
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Metastatic Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins60 enrolled1 locationNCT07142551
Recruiting
Phase 2
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins50 enrolled1 locationNCT06059118
Recruiting
Phase 2
The COSMYC Trial (COmbined Suppression of MYC)
Metastatic Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins50 enrolled1 locationNCT06922318